1.7100
-0.2000
(-10.47%)
At close: April 17 at 4:00:00 PM EDT
1.7100
0.00
(0.00%)
After hours: April 17 at 7:51:38 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,000
5,000
--
45,726
Operating Expense
72,551
72,551
67,270
54,372
Operating Income
-67,551
-67,551
-67,270
-8,646
Net Non Operating Interest Income Expense
-729
-729
117
-1,305
Other Income Expense
-35,948
-35,948
8,363
-46,727
Pretax Income
-104,228
-104,228
-58,790
-56,678
Tax Provision
643
643
--
--
Net Income Common Stockholders
-104,871
-104,871
-58,790
-56,678
Diluted NI Available to Com Stockholders
-104,871
-104,871
-58,790
-56,678
Basic EPS
-7.26
-7.26
-1.59
-1.54
Diluted EPS
-7.26
-7.26
-1.59
-1.54
Basic Average Shares
14,447.3560
14,447.3560
36,900.2680
36,900.2680
Diluted Average Shares
14,447.3560
14,447.3560
36,900.2680
36,900.2680
Total Operating Income as Reported
-67,551
-67,551
-67,270
-8,646
Total Expenses
72,551
72,551
67,270
54,372
Net Income from Continuing & Discontinued Operation
-104,871
-104,871
-58,790
-56,678
Normalized Income
-104,871
-104,871
-59,274
-56,718
Interest Income
62
62
550
32
Interest Expense
791
791
433
579
Net Interest Income
-729
-729
117
-1,305
EBIT
-103,437
-103,437
-58,357
-56,099
EBITDA
-101,215
-101,215
-56,316
-54,271
Reconciled Depreciation
2,222
2,222
2,041
1,828
Net Income from Continuing Operation Net Minority Interest
-104,871
-104,871
-58,790
-56,678
Total Unusual Items Excluding Goodwill
--
--
484
40
Total Unusual Items
--
--
484
40
Normalized EBITDA
-101,215
-101,215
-56,800
-54,311
Tax Rate for Calcs
0.0002
0.0002
--
--
12/31/2021 - 9/29/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IVBIY Innovent Biologics Inc.
22.29
0.00%
49B.F BeiGene, Ltd.
15.34
+0.07%
2162.HK Keymed Biosciences Inc.
42.650
+2.40%
IVBXF Innovent Biologics, Inc.
6.20
0.00%
ADAG Adagene Inc.
1.5300
0.00%
2157.HK Lepu Biopharma Co., Ltd.
3.960
+2.86%
AAPG Ascentage Pharma Group Internat
18.72
-0.79%
NRXS NeurAxis, Inc.
1.6000
-1.23%
GOVXW GeoVax Labs, Inc.
0.0331
0.00%
EPRX Eupraxia Pharmaceuticals Inc.
3.2900
+2.17%